SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IGT ((VSE:IGT) Blockbuster Anti-Cancer Test Results !!!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Flea who wrote (32)12/14/1997 10:34:00 AM
From: the Chief  Read Replies (1) of 94
 
Very True !!!!!!! IGT intends on an issue in the $1.20- $1.25 range to cover the costs associated with the clinical trials. Normally, onewould get "tense" on the thought of dillution, however, this company is already undervalued for its present potential. Assuming success on the clinical trials - and it truly will prove to be an irrelevant issue.

Still bullish on IGT,APQ,RKR

the Chief, in sunny Florida !!!(and assorted El Nino curses)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News